C12Y 203/01087
Aralkylamine n-acetyltransferase
Official title: Aralkylamine N-acetyltransferase (2.3.1.87)
C12Y203/01087 (Aralkylamine n-acetyltransferase) appears on 3 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 3
- Published applications
- 8
- Assignees
- 7
- Inventors
- 27
- Latest grant
- 19 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 1 |
| 2016 | 1 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 1 | 2 |
By publication year.
Recent patents
- Nitrilated psilocybin derivatives and methods of using19 Mar 2024US 11,931,338 B2Enveric Biosciences Canada Inc.
- Arylalkylamine N-acetyltransferase and uses thereof8 Sep 2020US 10,767,203 B2Danmarks Tekniske Universitet
- Melatonin-based treatment and diagnosis of bile duct disease18 Oct 2016US 9,468,670 B2Scott & White Healthcare
- Methods for producing tryptamine derivatives1 Aug 2024US 2024/0254533 A1
- Protein-based material for biocatalysis11 Apr 2024US 2024/0116992 A1Bondwell Technologies LP
- Advanced microbiome therapeutics engineered to produce serotonin in vivo30 Mar 2023US 2023/0098772 A1Danmarks Tekniske Universitet
- Nitrilated psilocybin derivatives and methods of using16 Feb 2023US 2023/0051548 A1Enveric Biosciences Canada Inc.
- Arylalkylamine n-acetyltransferase and uses thereof21 Nov 2019US 2019/0352684 A1Danmarks Tekniske Universitet
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.